Tools
Tools
Gill, Geoff, Yudkin, John S, Tesfaye, Solomon, de Courten, Maximilian, Gale, Edwin, Motala, Ayesha, Ramaiya, Kaushik, Unwin, Nigel and Wild, Sarah (2017) 'Essential medicines and access to insulin'. Lancet Diabetes and Endocrinology, Vol 5, Issue 5, pp. 324-325.
|
Text
Lancet_Essential medicines_15_3_17.pdf - Published Version Download (37kB) | Preview |
Abstract
We fully support the views expressed in The Lancet Diabetes & Endocrinology's Editorial about ensuring affordable access to insulin and the proposal to add analogue insulin to the WHO Essential Medicines list. The International Insulin Foundation in its 2011 position statement called for “the universal access for persons with type 1 diabetes to life-saving and life-preserving insulin”. In 2012, we launched the 100 Campaign, which sets the target of 100% affordability and 100% availability of insulin worldwide by the year 2022 (100 years after the introduction of insulin for people with diabetes).
| Item Type: | Article |
|---|---|
| Additional Information: | Correspondence. |
| Subjects: | W General Medicine. Health Professions > W 74 Medical economics. Health care costs WK Endocrine System > WK 810 Diabetes mellitus WK Endocrine System > WK 820 Insulin and its modifications |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
| Digital Object Identifer (DOI): | https://doi.org/10.1016/S2213-8587(17)30090-6 |
| SWORD Depositor: | JISC Pubrouter |
| Depositing User: | Stacy Murtagh |
| Date Deposited: | 13 Apr 2017 11:56 |
| Last Modified: | 18 Sep 2017 01:02 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/6980 |
Statistics
Actions (login required)
 |
Edit Item |